Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) - Forecasts from 2012 to 2017

Jan 16, 2013, 06:31 ET from Reportlinker

NEW YORK, Jan. 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017

http://www.reportlinker.com/p01083382/Metabolomics-Biomarker-Discovery/Metabolite-Detection/Metabolite-Profiling-Market-By-Applications-Drug-Discovery/Toxicology-Assessment/-Diagnosis-and-Indications-Oncology/Cardiology/Neurology-–-Forecasts-from-2012-to-2017 .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, metabolomics, a new science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a particular cellular process.

Metabolomics Market – Analysis of Global Technology, Application Trends and Landscape 2012-2017 report covers the market by disease indications along with the applications and metabolite profiling for biomarker discovery applications. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.

The Global Metabolomics market is showing a double digit growth (CAGR 35%) due to supportive factors such as, (i) increased willingness of biotechnology and pharma companies to adopt metabolomics concept to drive R&D activity within the industry, (ii) rapid growth of metabolomics data analysis softwares and solutions, and (iii) the advancement of analytical technologies. Metabolomics is used in the identification of new biomarkers, which indicate a change in the physiological state of a cell or tissue. Biomarker screening is important in the process of new drug discovery, and is also a key in vitro diagnostics tool. Additionally it is also being used for environmental toxicology screening. While, there are major concerns of this market such as the validation challenges, the positive aspects may very well offset the market restraints to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent developments and other strategic industry activities. These include: Metabolon Inc (U.S.), Metanomics (Germany), Metabolomic Technologies Inc. (U.S.), Human Metabolome Technologies (Japan), Beckman Coulter (U.S.), Agilent Technologies Inc (U.S.), Bruker Corporation (U.S.), Waters Corporation (U.S.), Biocrates Lifesciences (Austria), Chenomx Inc (Canada), Eisai co. ltd (Japan), Nextgen Metabolomics (U.S.), Phenomenome Discoveries Inc. (Canada) and Metabolomic Discoveries (Germany).

Scope of the Report

This technology report categorizes the market for metabolomics by geographical region (including the important countries in each region), applications, and indications, forecasting the market value in revenue by analyzing the trends in detection instruments and separation techniques (E.g. HPLC, Capillary Electrophoresis).A detailed description of global technological developments and evolving trends in the field of metabolomics with key prominence on product innovations by industries and collaborative efforts by the academic research institutions.A comprehensive picture of different types of detection instruments available for metabolite analysis (e.g. Mass Spectrometry, NMR, Electrochemical detection and Ion mobility spectrometer), prioritized based on critical criterias through Analytical Hierarchy Process (AHP).An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of metabolomics market during the forecast period from 2012 to 2017.Market size - Global market forecast for the next 5 years from 2012 – 2017 by including demand side analysis and strategic recommendations for technology/product developers.Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants.

TABLE OF CONTENTS 1. INTRODUCTION 13-18

1.1 Key Take-Aways 141.2 Report Scope 151.3 Research Methodology 171.4 Key Data Points From Secondary Sources 18

2. EXECUTIVE SUMMARY 19-22

3. METABOLOMICS –TECHNOLOGY LANDSCAPE ANALYSIS 23-44 3.1 Introduction 24

3.2 Metabolomics and Metabonomics 25

3.3 Separation Techniques - High Performance Liquid Chromatography (HPLC) 26

3.4 Separation Techniques – Capillary Electrophoresis (CE) 27

3.5 Detection Techniques – Mass Spectrometry (MS) 28

3.6 Detection Techniques – Nuclear Magnetic Resonance (NMR) 29

3.7 Detection Techniques – Surface Based Mass Analysis 30

3.8 Key Application Areas 31

3.8.1 Biomarker Discovery 32

3.8.2 Drug Discovery 33

3.8.3 Toxicity Assessment/Toxicology 34

3.8.4 Nutri-Genomics 35

3.9 Conceptual Approach 36

3.9.1 Target Analysis 37

3.9.2 Metabolite Profiling 38

3.9.3 Metabolite Fingerprinting 39

3.10 Technology Trends in Metabolomics 40

3.11 Value Chain Analysis 42

4. METABOLOMICS – MARKET LANDSCAPE ANALYSIS 45-69 4.1 Global Metabolomics Market Segmentation 46

4.2 Market Forecast 47

4.2.1 Global Metabolomics Market Revenue Forecast – Introduction 47

4.2.2 Global Metabolomics Market Revenue – Regional 48

4.2.3 Global Metabolomics Market Revenue – Indication 50

4.2.4 Global Metabolomics Market Revenue, By Application 56

4.3 Market Dynamics 62

4.3.1 Drivers 62

4.3.2 Restraints 65

4.3.3 Challenges 67

4.3.4 Emerging Trends 68

4.4 Demand Side Analysis 69

5. METABOLOMICS - TECHNOLOGY INVESTMENT POTENTIAL 70-81 5.1 Investment Climate Assessment 71

5.1.1 Investment Client Networks 72

5.1.1.1 Funding Bodies 73

5.1.1.2 Insights on Current & Future Tech-investment Trend 75

5.1.2 Funding Opportunities 76

5.1.3 Analysis of Potential Areas for Technology Investment using Strategic Evaluation 77

6. METABOLOMICS – GEOGRAPHICAL ANALYSIS 82-87 6.1 Introduction 83

6.2 U.S., Canada, Mexico 84

6.3 Europe 85

6.4 Asia & Rest of the World (ROW) 86

7. COMPETITIVE LANDSCAPE ANALYSIS 88-91 7.1 Mergers & Acquisitions 89

7.2 New Product Developments 90

7.3 Collaborations 91

8. PATENT ANALYSIS 92-93 8.1 Patent Analysis 939. TECHNOLOGY ANALYSIS (USING MULTI CRITERIA DECISION MAKING) & ROAD MAPPING 94-100 9.1 Level 0 Criteria Description 97

9.2 Comparison of Devices Based on Level 0 Criteria 98

9.3 Technology Prioritization and AHP Analysis Findings 99

9.4 Technology Roadmap 100

10 ANALYST INSIGHTS & RECOMMENDATIONS 101-104 10.1 Analyst Insights 102

10.2 Strategic Recommendations for Technology & Business Management 103

11 COMPANY PROFILES 105-126 11.1 AGILENT TECHNOLOGIES 106

11.2 BRUKER CORPORATION 107

11.3 METABOLOMIC TECHNOLOGIES 108

11.4 METABOLON 109

11.5 CHENOMX 110

11.6 BIO-RAD LABORATORIES 111

11.7 WATERS CORPORATION 112

11.8 HUMAN METABOLOME TECHNOLOGIES 113

11.9 NEXTGEN METABOLOMICS 114

11.10 BIOCRATES LIFE SCIENCES AG 115

11.11 STEMINA BIOMARKER 116

11.12 PHENOMENOME 117

11.13 METANOMICS GMBH 118

11.14 ACCELRYS 119

11.15 EISAI CO. LTD. 120

11.16 SHIMADZU CORPORATION 121

11.17 SIDMAP, LLC 122

11.18 ASTRAZENECA PLC 123

11.19 AB SCIEX 124

11.20 METABOLOMX 125

11.21 RESEARCH INSTITUTE OF CHROMATOGRAPHY (RIC) 126

12 APPENDIX 127-132 12.1 Key Patents 13113 GLOSSARY 133-134List of Tables 1 Global Metabolomics Market Revenue, by Regional ($Million) 48

2 Global Metabolomics Market Revenue, by Indication ($Million) 50

3 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Oncology Indication 51

4 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Cardiology Indication 52

5 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Neurology Indication 53

6 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Indications 54

7 Global Metabolomics Market Revenue, By Application ($Million) 56

8 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Bio Marker Discovery Application 57

9 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Drug Discovery Application 58

10 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Toxicology Testing Application 59

11 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Applications 60

List of Other Tables 1 Market Dynamics-Drivers Impact By Timeline 64

2 Market Dynamics-Restraints Impact By Timeline 66

3 Opportunity Strategic Evaluation Analysis 78

4 Mergers And Acquisitions 89

5 New Product Developments 90

6 Collaborations 91

7 Key Patents 131-132

List of Figures

FIG 1 Research Methodology 17FIG 2 Global Metabolomics Market Revenue, 2012 – 2017 ($Million) 20FIG 3 Market Share By Region, 2012 – 2017 (%) 21FIG 4 Key Application Areas 31FIG 5 Flow chart of Nutri-Genomics 35FIG 6 Conceptual Approach 36FIG 7 Value Chain Analysis 42FIG 8 Percentage of stake holders in metabolomics value chain 43FIG 9 Global Metabolomics Market Segmentation 46FIG 10 Global Metabolomics Market Revenue Forecast, 2012 - 2017 ($Million) 47FIG 11 Global Metabolomics Market Revenue, by Regional ($Million) 48FIG 12 Global Metabolomics Market Y-O-Y Growth Rate, By Region 48FIG 13 Market Share, By Region, 2012 – 2017 (%) 49FIG 14 Global Metabolomics Market Revenue, by Indication ($Million) 50FIG 15 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Oncology Indication 51FIG 16 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Cardiology Indication 52FIG 17 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Neurology Indication 53FIG 18 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Indications 54FIG 19 Global Market Share, By Indication, 2012 – 2017 (%) 55FIG 20 Global Metabolomics Market Revenue, By Application ($Million) 56FIG 21 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Bio Marker Discovery Application 57FIG 22 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Drug Discovery Application 58FIG 23 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Toxicology Testing Application 59FIG 24 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Applications 60FIG 25 Global Percentage Distribution of Metabolomics Market, By Applications, 2012 – 2017 (%) 61FIG 26 Demand Side Analysis 69FIG 27 Investment Client Networks 72FIG 28 Opportunity Strategic Evaluation Analysis 78FIG 29 Regions with High Technology Adoption 87FIG 30 Patent Distribution Among Top Players 93FIG 31 AHP Analysis 95FIG 32 Priority Values 96FIG 33 Comparison of Devices Based on Level 0 Criteria 98FIG 34 Technology Prioritization and AHP Analysis Findings 99FIG 35 Technology Roadmap 100FIG 36 Strategic Recommendations for Technology & Business Management 103

To order this report:General_Medicine_and_Specialty_Medicine Industry: Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017

Nicolas Bombourg

Reportlinker

Email: nicolasbombourg@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com